| Autor: |
Kurmashov VI, Gavrilova IE, Maiakova SA, Popa AV, Morozova OV, Ivanova LF, Kurdiukov BV, Gavrikova NV, Il'iashenko VV, Terzich M |
| Jazyk: |
ruština |
| Zdroj: |
Voprosy onkologii [Vopr Onkol] 1997; Vol. 43 (4), pp. 456-9. |
| Abstrakt: |
The tolerance of cardioxan (JCRF-187, dexrazoxan), an ethylenediamine tetra-acetic acid analog and a Chiron Company product, administered to pediatric oncohematological patients, is discussed. The drug was used in 37 cases of acute lymphoblastic and non-lymphoblastic leukemia, non-Hodgkin's lymphoma and Hodgkin's disease treated by polychemotherapy including anthracycline antibiotics administration. No untoward side-effects or inhibition of the therapeutic effect were observed. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
